Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2026-01-25 @ 6:02 PM
Study NCT ID:
NCT02318095
Status:
COMPLETED
Last Update Posted:
2023-10-26
First Post:
2014-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine/Nab-Paclitaxel With HIGRT in Resectable Pancreatic Cancer
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-14
Completion Date Type:
ACTUAL
First Submit Date:
2014-12-12
First Submit QC Date:
None
Study First Post Date:
2014-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-10
Results First Submit QC Date:
None
Results First Post Date:
2021-07-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-23
Last Update Post Date:
2023-10-26
Last Update Post Date Type:
ACTUAL